<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02903017</url>
  </required_header>
  <id_info>
    <org_study_id>KIA 2016/196</org_study_id>
    <nct_id>NCT02903017</nct_id>
  </id_info>
  <brief_title>Local Administration of Tranexamic Acid in Upper Gastrointestinal Hemorrhage</brief_title>
  <official_title>Local Administration of Tranexamic Acid in Upper Gastrointestinal Hemorrhage: A Double-Blind, Randomized, Placebo-Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kocaeli University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kocaeli University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Upper gastrointestinal hemorrhage is a frequently diagnosis in emergency departments.
      Although new drugs and endoscopic techniques were easily applied in various settings in this
      condition, the role of local administered therapies such as antifibrinolytic agents remain
      unclear. The investigators aimed to compare standard therapy (proton pump inhibitors,
      endoscopic treatments etc.) and standard therapy + local administered tranexamic acid in
      upper gastrointestinal hemorrhage in a double-blind, randomized trial.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2016</start_date>
  <completion_date type="Actual">March 2018</completion_date>
  <primary_completion_date type="Actual">March 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mortality</measure>
    <time_frame>One month</time_frame>
    <description>In- or out of hospital mortality</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Re-bleeding</measure>
    <time_frame>One month</time_frame>
    <description>Recurrent upper gastrointestinal hemorrhage</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Endoscopic intervention need</measure>
    <time_frame>One month</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Surgical intervention need</measure>
    <time_frame>One month</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>ED revisit</measure>
    <time_frame>One month</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Length of stay in the hospital</measure>
    <time_frame>One month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Administered blood products in the ED</measure>
    <time_frame>One month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse reactions</measure>
    <time_frame>One month</time_frame>
    <description>Thromboembolic events, anaphylaxis</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">114</enrollment>
  <condition>Gastrointestinal Hemorrhage</condition>
  <condition>Tranexamic Acid</condition>
  <condition>Emergency Department</condition>
  <condition>Antifibrinolytic Agents</condition>
  <arm_group>
    <arm_group_label>Tranexamic acid 5%</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Tranexamic acid 5%, 2000 mg (40 mL) in 60 mL normal saline (0.9%) solution (total 100 mL)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>0.9% normal saline solution (total 100 mL)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tranexamic acid 5%</intervention_name>
    <description>Via nasogastric tube, 100 mL</description>
    <arm_group_label>Tranexamic acid 5%</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Via nasogastric tube, 100 mL</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients presenting with upper gastrointestinal hemorrhage to the ED

          -  Patients older than 18 years

          -  Patients who agree to participate the study by reading and signing the informed
             consent form

        Exclusion Criteria:

          -  Patients younger than 18 years

          -  Patients who do not agree to participate the study

          -  Documented or declared allergy to tranexamic acid

          -  Upper gastrointestinal hemorrhage secondary to trauma

          -  Upper gastrointestinal hemorrhage secondary to esophageal varices

          -  Patients who cannot undergo to endoscopy for any reason

          -  History for thromboembolic disease

          -  Patients with renal impairment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nurettin Özgür Doğan, M.D., Assoc. Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kocaeli University, Faculty of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kocaeli University, Faculty of Medicine</name>
      <address>
        <city>Kocaeli</city>
        <zip>41050</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Hawkey GM, Cole AT, McIntyre AS, Long RG, Hawkey CJ. Drug treatments in upper gastrointestinal bleeding: value of endoscopic findings as surrogate end points. Gut. 2001 Sep;49(3):372-9.</citation>
    <PMID>11511559</PMID>
  </reference>
  <reference>
    <citation>Bergqvist D, Dahlgren S, Hessman Y. Local inhibition of the fibrinolytic system in patients with massive upper gastrointestinal hemorrhage. Ups J Med Sci. 1980;85(2):173-8.</citation>
    <PMID>7018048</PMID>
  </reference>
  <reference>
    <citation>Cormack F, Chakrabarti RR, Jouhar AJ, Fearnley GR. Tranexamic acid in upper gastrointestinal haemorrhage. Lancet. 1973 Jun 2;1(7814):1207-8.</citation>
    <PMID>4122561</PMID>
  </reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 12, 2016</study_first_submitted>
  <study_first_submitted_qc>September 15, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 16, 2016</study_first_posted>
  <last_update_submitted>March 5, 2018</last_update_submitted>
  <last_update_submitted_qc>March 5, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 6, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kocaeli University</investigator_affiliation>
    <investigator_full_name>Nurettin Özgür Doğan</investigator_full_name>
    <investigator_title>M.D., Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Emergencies</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Gastrointestinal Hemorrhage</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tranexamic Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

